LawrenceHEinhornMD

Oncology • Indianapolis, IN

Professor, Medicine, Indiana University School of Medicine

Join to view full profile

Dr. Einhorn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Einhorn's full profile

Already have an account?

Office
535 Barnhill Dr
Rt 473
Indianapolis, IN 46202
Phone+1 317-274-3515

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1972 - 1973
Indiana University School of MedicineResidency, Internal Medicine, 1968 - 1969
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 1967 - 1968
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1967

Certifications & Licensure

CA State Medical License 1971 - Present
IN State Medical License 1971 - 2025
IA State Medical License 1968 - 1988
OH State Medical License 1968 - 1972
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Indianapolis Monthly Castle Connolly, 2007, 2009-2011, 2013
Fellow (FASCO) American Society of Clinical Oncologists, 2007
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors Start of enrollment: 1999 Jan 25
Completed
Phase 2
A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR Start of enrollment: 2002 Sep 01
Terminated
Phase 2
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors Start of enrollment: 2000 Oct 01
Terminated
Phase 2
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients Start of enrollment: 2006 Oct 01
Completed
Phase 2
Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors Start of enrollment: 2007 Dec 01
Completed
Phase 3
Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies Start of enrollment: 2009 Mar 01
Completed
Phase 1
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11
Terminated
Phase 3
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors Start of enrollment: 2013 Jan 01
Completed
Phase 2
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors Start of enrollment: 2013 Feb 01
Terminated
Phase 2
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer.
Sarah L Kerns, Paul C Dinh Jr, Patrick O Monahan, Timothy Stump, Chunkit Fung
Journal of the National Cancer Institute. 2025-02-03
-Rearranged Non-Small Cell Lung Cancer Presenting as a Large Mediastinal Mass: A Case Report.
Urs M Weber, Lawrence Einhorn, Paul A Bunn
JCO Precision Oncology. 2025-02-01
Prediction Model for Brain Metastasis in Patients With Metastatic Germ-Cell Tumors.
Tareq Salous, Ryan Ashkar, Sandra K Althouse, Clint Cary, Timothy Masterson
Cancer Medicine. 2025-02-01

Journal Articles

Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration
Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology

Press Mentions

The Formative Years of Medical Oncology in the United States: A Rough and Tumble Road, Part 2October 10th, 2024
Patients Praise IU Health Physician Known for Testicular Cancer TreatmentApril 25th, 2022
The Importance of Having Mentors, Both Locally and GloballyMarch 11th, 2020
Join now to see all

Grant Support

Core--Prognostic ModelingNational Cancer Institute1999–2001
Biology Of High Risk Germ Cell NeoplasiaNational Cancer Institute1999–2001
Clinical Trials In OncologyNational Cancer Institute1994–1998
Ly213514 (Thymidylate Synthase Inhibitor) With Metastatic Colorectal CancerNational Center For Research Resources1997
Intrapleural Batimastat With Malignant Pleural EffusionNational Center For Research Resources1997
OncologyNational Cancer Institute1994
Clinical Trials In Human OncologyNational Cancer Institute1992–1993
Eastern Cooperative Oncology GroupNational Cancer Institute1989–1993
Nci-Outstanding Investigator GrantNational Cancer Institute1985–1991
Southeastern Cancer Study GroupNational Cancer Institute1985–1986

Professional Memberships

American Society of Clinical Oncology - ASCO
Fellow